Literature DB >> 22925227

A sad but forgotten truth: the story of slow-moving solutes in fast hemodialysis.

Sunny Eloot1, Wim Van Biesen, Raymond Vanholder.   

Abstract

When trying to optimize hemodialysis adequacy, it can be questioned whether one should focus on the dialyzer or on the patient. Another crucial question is whether the currently applied dialysis adequacy parameter, Kt/V(urea) , is a reliable marker. For the small and water-soluble solutes, recent advances in convective strategies and/or new dialyzer designs do not add much removal capacity. Depending on their specific kinetics, generally quite different from those of urea, small solute removal benefits from longer or more frequent dialysis. Clearance of beta-2-microglobulin (β(2) M), a marker of middle molecule removal pattern, is improved with dialysis using more open and permselective membranes, as well as by using high convective volume strategies. Furthermore, longer and more frequent dialyses have highly favorable removal characteristics because they facilitate the retarded transport between plasmatic and extraplasmatic compartments over which these molecules are distributed. As β(2) M may not be representative of other middle molecules, future kinetic analyses of alternative middle molecules will be of the utmost interest. Protein-bound solute clearance is improved by convective techniques, but not by more open dialyzer pores. Knowledge of their kinetics should be helpful in interpreting the observation that frequent (but not longer) dialysis enhances protein-bound solute removal. Hence, further technical improvements in dialyzers will have only a minor impact on dialysis adequacy, as retarded solute movement in the patient plays a decisive role. As urea kinetics is not representative of the kinetics of protein-bound compounds, middle molecules, nor even of other small and water-soluble solutes, it becomes self-evident that urea clearance is a poor predictor of many aspects of dialysis adequacy.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22925227     DOI: 10.1111/j.1525-139X.2012.01107.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  8 in total

1.  Dialysis: Small solute uraemic toxin generation and adequacy of dialysis.

Authors:  Pieter M ter Wee
Journal:  Nat Rev Nephrol       Date:  2013-06-04       Impact factor: 28.314

2.  Dialyzer Reuse and Outcomes of High Flux Dialysis.

Authors:  Christos Argyropoulos; Maria-Eleni Roumelioti; Abdus Sattar; John A Kellum; Lisa Weissfeld; Mark L Unruh
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

3.  Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators.

Authors:  Tariq Shafi; Timothy W Meyer; Thomas H Hostetter; Michal L Melamed; Rulan S Parekh; Seungyoung Hwang; Tanushree Banerjee; Josef Coresh; Neil R Powe
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

Review 4.  Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In Silico.

Authors:  Maria Eleni Roumelioti; Thomas Nolin; Mark L Unruh; Christos Argyropoulos
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

5.  New low-flux mixed matrix membranes that offer superior removal of protein-bound toxins from human plasma.

Authors:  Denys Pavlenko; Esmée van Geffen; Mies J van Steenbergen; Griet Glorieux; Raymond Vanholder; Karin G F Gerritsen; Dimitrios Stamatialis
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

6.  Carbon Adsorbents With Dual Porosity for Efficient Removal of Uremic Toxins and Cytokines from Human Plasma.

Authors:  D Pavlenko; D Giasafaki; G Charalambopoulou; E van Geffen; K G F Gerritsen; T Steriotis; D Stamatialis
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

7.  Proactive Risk Assessment Through Failure Mode and Effect Analysis (FMEA) for Haemodialysis Facilities: A Pilot Project.

Authors:  Raffaele La Russa; Valentina Fazio; Michela Ferrara; Nicola Di Fazio; Rocco Valerio Viola; Gianluca Piras; Giuseppe Ciano; Fausta Micheletta; Paola Frati
Journal:  Front Public Health       Date:  2022-03-24

8.  Design and Development of a Computational Tool for a Dialyzer by Using Computational Fluid Dynamic (CFD) Model.

Authors:  Tuba Yaqoob; Muhammad Ahsan; Sarah Farrukh; Iftikhar Ahmad
Journal:  Membranes (Basel)       Date:  2021-11-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.